A meta-analysis based on abnormal ALT at various thresholds and comparison with imaging reported that the estimated NAFLD prevalence was 7% and 14% in the general population (by nine studies) and in children with obesity (by 14 studies), respectively [36]. This evidence concerns the gene GPT and metabolic dysfunction-associated steatotic liver disease.